Cleared Traditional

620CSR DISPLAY DRIVER (K932894) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K932894 · Vidco, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1994
Decision
371d
Days
Class 2
Risk

K932894 is an FDA 510(k) clearance for the 620CSR DISPLAY DRIVER. Classified as Display, Cathode-ray Tube, Medical (product code DXJ), Class II - Special Controls.

Submitted by Vidco, Inc. (Beaverton, US). The FDA issued a Cleared decision on June 20, 1994 after a review of 371 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2450 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Vidco, Inc. devices

Submission Details

510(k) Number K932894 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 14, 1993
Decision Date June 20, 1994
Days to Decision 371 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
246d slower than avg
Panel avg: 125d · This submission: 371d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DXJ Display, Cathode-ray Tube, Medical
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2450
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXJ Display, Cathode-ray Tube, Medical

All 24
Devices cleared under the same product code (DXJ) and FDA review panel - the closest regulatory comparables to K932894.
INFINITY EXPLORER
K013515 · Siemens Medical Solutions USA, Inc. · Jan 2002
HP CAREVUE 9000 CLINICAL INFORMATION SYSTEM, MODEL M2331A
K992636 · Hewlett-Packard Co. · Aug 1999
HEWLETT-PACKARD MODEL M1490A WIRELESS PATIENT DATA COMMUNICATOR
K945277 · Hewlett-Packard Co. · Jan 1995
MODEL M1251A MON. FULL DISCLOSURE REVIEW SYSTEM
K905788 · Hewlett-Packard Co. · Jun 1991
MODEL VY-800RA OPTIONAL ACCESSORY TO BSM 8500A
K883973 · Nihon Kohden America, Inc. · Nov 1988
Q-CATH RM
K883031 · Quinton, Inc. · Sep 1988